Financial Statements
Bayer Group Consolidated Statements of Cash Flows
| 3rd Quarter 2007 | 3rd Quarter 2008 | First Nine Months 2007 | First Nine Months 2008 | |
| € million | ||||
| Income from continuing operations after taxes | 1,180 | 275 | 2,249 | 1,618 |
| Income taxes | (769) | 133 | (221) | 701 |
| Non-operating result | 266 | 276 | 741 | 813 |
| Income taxes paid | (201) | (197) | (886) | (913) |
| Depreciation and amortization | 762 | 650 | 2,016 | 2,031 |
| Change in pension provisions | (116) | (5) | (298) | (185) |
| (Gains) losses on retirements of noncurrent assets | (8) | (12) | (2) | (78) |
| Non-cash effects of the remeasurement of acquired assets (inventory work-down) | 51 | 51 | 164 | 157 |
| Gross cash flow | 1,165 | 1,171 | 3,763 | 4,144 |
| Decrease (increase) in inventories | (107) | (299) | (282) | (563) |
| Decrease (increase) in trade accounts receivable | 397 | 377 | (666) | (697) |
| (Decrease) increase in trade accounts payable | 1 | (78) | (97) | (143) |
| Changes in other working capital, other non-cash items | 167 | 63 | 96 | (90) |
| Net cash provided by (used in) operating activities (net cash flow), continuing operations | 1,623 | 1,234 | 2,814 | 2,651 |
| Net cash provided by (used in) operating activities (net cash flow), discontinued operations | (2) | 0 | 0 | 0 |
| Net cash provided by (used in) operating activities (net cash flow) (total) | 1,621 | 1,234 | 2,814 | 2,651 |
| Cash outflows for additions to property, plant, equipment and intangible assets | (482) | (492) | (1,123) | (1,127) |
| Cash inflows from sales of property, plant, equipment and other assets | 89 | 41 | 120 | 148 |
| Cash inflows (outflows) from divestitures less divested cash | (111) | (3) | 4,792 | (52) |
| Cash inflows (outflows) for acquisitions less acquired cash | (198) | (367) | (455) | (919) |
| Cash inflows (outflows) from noncurrent financial assets | 1 | 25 | 9 | 73 |
| Interest and dividends received | 96 | 126 | 565 | 424 |
| Cash (inflows) outflows from current financial assets | 2 | 3 | 25 | 1 |
| Net cash provided by (used in) investing activities (total) | (603) | (667) | 3,933 | (1,452) |
| Capital contributions | - | - | - | - |
| Bayer AG dividend and dividend payments to minority stockholders | 0 | (2) | (775) | (1,042) |
| Issuances of debt | 239 | 103 | 1,842 | 1,102 |
| Retirements of debt | (1,555) | (166) | (7,051) | (465) |
| Interest paid | (222) | (267) | (1,207) | (1,023) |
| Net cash provided by (used in) financing activities (total) | (1,538) | (332) | (7,191) | (1,428) |
| Change in cash and cash equivalents due to business activities (total) | (520) | 235 | (444) | (229) |
| Cash and cash equivalents at beginning of period | 2,980 | 2,058 | 2,915 | 2,531 |
| Change in cash and cash equivalents due to changes in scope of consolidation | 1 | 0 | (3) | 2 |
| Change in cash and cash equivalents due to exchange rate movements | (80) | (12) | (87) | (23) |
| Cash and cash equivalents at end of period | 2,381 | 2,281 | 2,381 | 2,281 |



Overview of Sales, Earnings and Financial Position
Statements of Cash Flows
Bayer Links
Investor Relations

Bookmark this page
E-mail this page
Advanced Search

